お知らせ :東京証券取引所JASDAQスタンダード市場への新規上場に関するお知らせ

株式会社グローバルインフォメーション
表紙
市場調査レポート
商品コード
909347

組織診断の世界市場

Tissue Diagnostics

出版日: | 発行: Global Industry Analysts, Inc. | ページ情報: 英文 376 Pages | 納期: 即日から翌営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=104.53円

ご注意:Single user licenseはDRM(デジタル著作権管理システム)付PDFとなります。
PDFの閲覧には Adobe Digital Editions (無償)のインストールが必要となります。
認証されたPC上のみでの閲覧と、1回のプリントアウトが可能となっております。

組織診断の世界市場
出版日: 2020年09月01日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 376 Pages
納期: 即日から翌営業日
担当者のコメント
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

当レポートでは、世界における組織診断市場の概要、動向・発展への影響因子の分析、競合企業と市場シェア、世界および地域・主要国別の市場規模の推移と予測、主要企業のプロファイルなどをまとめています。

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
    • 世界市場における企業シェア
    • 世界の組織診断市場における企業シェアのシナリオ
  • 主要企業
  • 市場の動向と発展因子
  • 世界市場の見通し

第3章 市場分析

  • 地域別市場の分析
    • 米国
    • カナダ
    • 日本
    • 中国
    • 欧州
    • フランス
    • ドイツ
    • イタリア
    • 英国
    • スペイン
    • ロシア
    • その他欧州
    • アジア太平洋地域
    • オーストラリア
    • インド
    • 韓国
    • その他アジア太平洋地域
    • ラテンアメリカ
    • アルゼンチン
    • ブラジル
    • メキシコ
    • その他ラテンアメリカ
    • 中東
    • イラン
    • イスラエル
    • サウジアラビア
    • アラブ首長国連邦
    • その他中東
    • アフリカ

第4章 競合企業

  • ABBOTT LABORATORIES
  • ABCAM PLC
  • AGILENT TECHNOLOGIES
  • BIO SB, INC.
  • BIOGENEX
  • CELL SIGNALING TECHNOLOGY
  • DANAHER CORPORATION
  • F. HOFFMANN-LA ROCHE AG
  • MERCK & CO.
  • QIAGEN NV
  • SAKURA FINETEK JAPAN CO.,LTD.
  • THERMO FISHER SCIENTIFIC

第5章 調査資料

目次
Product Code: MCP15240

Global Tissue Diagnostics Market to Reach US$5.3 Billion by the Year 2027

Amid the COVID-19 crisis, the global market for Tissue Diagnostics estimated at US$3.8 Billion in the year 2020, is projected to reach a revised size of US$5.3 Billion by 2027, growing at a CAGR of 4.9% over the period 2020-2027.Consumables, one of the segments analyzed in the report, is projected to grow at a 5.5% CAGR to reach US$3.7 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Instruments segment is readjusted to a revised 3.8% CAGR for the next 7-year period. This segment currently accounts for a 32.8% share of the global Tissue Diagnostics market.

The U.S. Accounts for Over 27.2% of Global Market Size in 2020, While China is Forecast to Grow at a 8.4% CAGR for the Period of 2020-2027

The Tissue Diagnostics market in the U.S. is estimated at US$1 Billion in the year 2020. The country currently accounts for a 27.24% share in the global market. China, the world second largest economy, is forecast to reach an estimated market size of US$1.1 Billion in the year 2027 trailing a CAGR of 8.4% through 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 2.3% and 4.6% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 2.8% CAGR while Rest of European market (as defined in the study) will reach US$1.1 Billion by the year 2027.We bring years of research experience to this 7th edition of our report. The 376-page report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed.

Competitors identified in this market include, among others,

  • Abbott Laboratories
  • Abcam plc
  • Agilent Technologies
  • Becton, Dickinson and Company
  • Bio SB
  • Bio-Genex Laboratories
  • Cell Signaling Technology Inc.
  • F. Hoffmann-La Roche Ltd
  • Leica Biosystems Nussloch GmbH
  • Merck KGaA
  • QIAGEN N.V.
  • Sakura Finetek Japan Co. Ltd.
  • Thermo Fisher Scientific Inc.

TABLE OF CONTENTS

I. INTRODUCTION, METHODOLOGY & REPORT SCOPE

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Impact of Covid-19 and a Looming Global Recession
    • Tissue Diagnostics Market: Prelude
    • Immunohistochemistry Emerges as the Major Tissue Diagnostic Test
    • Breast Cancer Leads the Application Market for Tissue Diagnostics
    • Hospitals Represent the Leading End-Use Segment
    • Developed Regions Lead, Developing Economies to Spearhead Growth
    • Impact of COVID-19 on Healthcare & Pharmaceutical Industries
    • Competition
    • Recent Market Activity
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Cancer Incidence Worldwide Spurs Demand for Tissue Diagnostics
    • Global Cancer Incidence: Number of New Cancer Cases in Million for the Years 2018, 2020, 2025, 2030, 2035 and 2040
    • Global Number of New Cancer Cases and Cancer-related Deaths by Cancer Site for 2018
    • Number of New Cancer Cases and Deaths (in Million) by Region for 2018
    • Global Number of New Cancer Cases (in Million) in Men by Cancer Site: 2018
    • Global Number of New Cancer Deaths (in Million) in Men by Cancer Site: 2018
    • Global Number of New Cancer Cases (in Million) in Women by Cancer Site: 2018
    • Global Number of New Cancer Deaths (in Million) in Women by Cancer Site: 2018
    • Aging Population and Changing Lifestyles Drive Cancer Incidence, Fueling Prospects for Tissue Diagnostics Market
    • Global Aging Population: Population of 65+ Individuals (in Thousands) by Region for 2019 and 2030
    • Global Population of 65+ Individuals as % of Total Population by Region for 2019 and 2030
    • Elderly Population (65+ Years) as a % of Total Population by Developed, Less Developed and Least Developed Regions: 2019 & 2030
    • Global Cancer Deaths by Age Group (in %) for 2019
    • Increasing Healthcare Spending Levels Augur Well for the Market
    • Global Healthcare Market Size in $ Billion for the Years 2018-2022
    • Healthcare Expenditure as a % of GDP by Region for 2019
    • Per Capita Healthcare Spending (in $) in Select Countries for the Year 2019
    • Growing Significance of Personalized Medicine: An Opportunity for Tissue Diagnostics Market
    • Global Personalized Medicine Market: Revenues in US$ Million for the Years 2019 and 2024
    • Liquid Biopsies Grow in Value as a Diagnostic Tool Supporting Therapy Decisions in NSCLCs
    • Sustained Advancements in Tissue Diagnostics Space Fuel Market Prospects
    • Market Poised to Benefit from Digitalization of Tissue Diagnostic Techniques & Automated Tissue Diagnostic Systems
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Current & Future Analysis for Tissue Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Billion for Years 2020 through 2027
    • TABLE 2: World Historic Review for Tissue Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Billion for Years 2012 through 2019
    • TABLE 3: World 15-Year Perspective for Tissue Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2012, 2020 & 2027
    • TABLE 4: World Current & Future Analysis for Consumables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Billion for Years 2020 through 2027
    • TABLE 5: World Historic Review for Consumables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Billion for Years 2012 through 2019
    • TABLE 6: World 15-Year Perspective for Consumables by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
    • TABLE 7: World Current & Future Analysis for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Billion for Years 2020 through 2027
    • TABLE 8: World Historic Review for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Billion for Years 2012 through 2019
    • TABLE 9: World 15-Year Perspective for Instruments by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
    • TABLE 10: World Current & Future Analysis for Immunohistochemistry by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Billion for Years 2020 through 2027
    • TABLE 11: World Historic Review for Immunohistochemistry by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Billion for Years 2012 through 2019
    • TABLE 12: World 15-Year Perspective for Immunohistochemistry by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
    • TABLE 13: World Current & Future Analysis for in Situ Hybridization by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Billion for Years 2020 through 2027
    • TABLE 14: World Historic Review for in Situ Hybridization by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Billion for Years 2012 through 2019
    • TABLE 15: World 15-Year Perspective for in Situ Hybridization by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
    • TABLE 16: World Current & Future Analysis for Special Staining by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Billion for Years 2020 through 2027
    • TABLE 17: World Historic Review for Special Staining by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Billion for Years 2012 through 2019
    • TABLE 18: World 15-Year Perspective for Special Staining by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
    • TABLE 19: World Current & Future Analysis for Digital Pathology & Workflow by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Billion for Years 2020 through 2027
    • TABLE 20: World Historic Review for Digital Pathology & Workflow by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Billion for Years 2012 through 2019
    • TABLE 21: World 15-Year Perspective for Digital Pathology & Workflow by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
    • TABLE 22: World Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Billion for Years 2020 through 2027
    • TABLE 23: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Billion for Years 2012 through 2019
    • TABLE 24: World 15-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
    • TABLE 25: World Current & Future Analysis for Pharma Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Billion for Years 2020 through 2027
    • TABLE 26: World Historic Review for Pharma Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Billion for Years 2012 through 2019
    • TABLE 27: World 15-Year Perspective for Pharma Companies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
    • TABLE 28: World Current & Future Analysis for Research Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Billion for Years 2020 through 2027
    • TABLE 29: World Historic Review for Research Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Billion for Years 2012 through 2019
    • TABLE 30: World 15-Year Perspective for Research Laboratories by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
    • TABLE 31: World Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Billion for Years 2020 through 2027
    • TABLE 32: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Billion for Years 2012 through 2019
    • TABLE 33: World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027

III. MARKET ANALYSIS

  • GEOGRAPHIC MARKET ANALYSIS
  • UNITED STATES
    • TABLE 34: USA Current & Future Analysis for Tissue Diagnostics by Product - Consumables and Instruments - Independent Analysis of Annual Sales in US$ Billion for the Years 2020 through 2027
    • TABLE 35: USA Historic Review for Tissue Diagnostics by Product - Consumables and Instruments Markets - Independent Analysis of Annual Sales in US$ Billion for Years 2012 through 2019
    • TABLE 36: USA 15-Year Perspective for Tissue Diagnostics by Product - Percentage Breakdown of Value Sales for Consumables and Instruments for the Years 2012, 2020 & 2027
    • TABLE 37: USA Current & Future Analysis for Tissue Diagnostics by Technology - Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow - Independent Analysis of Annual Sales in US$ Billion for the Years 2020 through 2027
    • TABLE 38: USA Historic Review for Tissue Diagnostics by Technology - Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow Markets - Independent Analysis of Annual Sales in US$ Billion for Years 2012 through 2019
    • TABLE 39: USA 15-Year Perspective for Tissue Diagnostics by Technology - Percentage Breakdown of Value Sales for Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow for the Years 2012, 2020 & 2027
    • TABLE 40: USA Current & Future Analysis for Tissue Diagnostics by End-Use - Hospitals, Pharma Companies, Research Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Billion for the Years 2020 through 2027
    • TABLE 41: USA Historic Review for Tissue Diagnostics by End-Use - Hospitals, Pharma Companies, Research Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Billion for Years 2012 through 2019
    • TABLE 42: USA 15-Year Perspective for Tissue Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Pharma Companies, Research Laboratories and Other End-Uses for the Years 2012, 2020 & 2027
  • CANADA
    • TABLE 43: Canada Current & Future Analysis for Tissue Diagnostics by Product - Consumables and Instruments - Independent Analysis of Annual Sales in US$ Billion for the Years 2020 through 2027
    • TABLE 44: Canada Historic Review for Tissue Diagnostics by Product - Consumables and Instruments Markets - Independent Analysis of Annual Sales in US$ Billion for Years 2012 through 2019
    • TABLE 45: Canada 15-Year Perspective for Tissue Diagnostics by Product - Percentage Breakdown of Value Sales for Consumables and Instruments for the Years 2012, 2020 & 2027
    • TABLE 46: Canada Current & Future Analysis for Tissue Diagnostics by Technology - Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow - Independent Analysis of Annual Sales in US$ Billion for the Years 2020 through 2027
    • TABLE 47: Canada Historic Review for Tissue Diagnostics by Technology - Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow Markets - Independent Analysis of Annual Sales in US$ Billion for Years 2012 through 2019
    • TABLE 48: Canada 15-Year Perspective for Tissue Diagnostics by Technology - Percentage Breakdown of Value Sales for Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow for the Years 2012, 2020 & 2027
    • TABLE 49: Canada Current & Future Analysis for Tissue Diagnostics by End-Use - Hospitals, Pharma Companies, Research Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Billion for the Years 2020 through 2027
    • TABLE 50: Canada Historic Review for Tissue Diagnostics by End-Use - Hospitals, Pharma Companies, Research Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Billion for Years 2012 through 2019
    • TABLE 51: Canada 15-Year Perspective for Tissue Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Pharma Companies, Research Laboratories and Other End-Uses for the Years 2012, 2020 & 2027
  • JAPAN
    • TABLE 52: Japan Current & Future Analysis for Tissue Diagnostics by Product - Consumables and Instruments - Independent Analysis of Annual Sales in US$ Billion for the Years 2020 through 2027
    • TABLE 53: Japan Historic Review for Tissue Diagnostics by Product - Consumables and Instruments Markets - Independent Analysis of Annual Sales in US$ Billion for Years 2012 through 2019
    • TABLE 54: Japan 15-Year Perspective for Tissue Diagnostics by Product - Percentage Breakdown of Value Sales for Consumables and Instruments for the Years 2012, 2020 & 2027
    • TABLE 55: Japan Current & Future Analysis for Tissue Diagnostics by Technology - Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow - Independent Analysis of Annual Sales in US$ Billion for the Years 2020 through 2027
    • TABLE 56: Japan Historic Review for Tissue Diagnostics by Technology - Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow Markets - Independent Analysis of Annual Sales in US$ Billion for Years 2012 through 2019
    • TABLE 57: Japan 15-Year Perspective for Tissue Diagnostics by Technology - Percentage Breakdown of Value Sales for Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow for the Years 2012, 2020 & 2027
    • TABLE 58: Japan Current & Future Analysis for Tissue Diagnostics by End-Use - Hospitals, Pharma Companies, Research Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Billion for the Years 2020 through 2027
    • TABLE 59: Japan Historic Review for Tissue Diagnostics by End-Use - Hospitals, Pharma Companies, Research Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Billion for Years 2012 through 2019
    • TABLE 60: Japan 15-Year Perspective for Tissue Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Pharma Companies, Research Laboratories and Other End-Uses for the Years 2012, 2020 & 2027
  • CHINA
    • TABLE 61: China Current & Future Analysis for Tissue Diagnostics by Product - Consumables and Instruments - Independent Analysis of Annual Sales in US$ Billion for the Years 2020 through 2027
    • TABLE 62: China Historic Review for Tissue Diagnostics by Product - Consumables and Instruments Markets - Independent Analysis of Annual Sales in US$ Billion for Years 2012 through 2019
    • TABLE 63: China 15-Year Perspective for Tissue Diagnostics by Product - Percentage Breakdown of Value Sales for Consumables and Instruments for the Years 2012, 2020 & 2027
    • TABLE 64: China Current & Future Analysis for Tissue Diagnostics by Technology - Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow - Independent Analysis of Annual Sales in US$ Billion for the Years 2020 through 2027
    • TABLE 65: China Historic Review for Tissue Diagnostics by Technology - Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow Markets - Independent Analysis of Annual Sales in US$ Billion for Years 2012 through 2019
    • TABLE 66: China 15-Year Perspective for Tissue Diagnostics by Technology - Percentage Breakdown of Value Sales for Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow for the Years 2012, 2020 & 2027
    • TABLE 67: China Current & Future Analysis for Tissue Diagnostics by End-Use - Hospitals, Pharma Companies, Research Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Billion for the Years 2020 through 2027
    • TABLE 68: China Historic Review for Tissue Diagnostics by End-Use - Hospitals, Pharma Companies, Research Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Billion for Years 2012 through 2019
    • TABLE 69: China 15-Year Perspective for Tissue Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Pharma Companies, Research Laboratories and Other End-Uses for the Years 2012, 2020 & 2027
  • EUROPE
    • TABLE 70: Europe Current & Future Analysis for Tissue Diagnostics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Billion for Years 2020 through 2027
    • TABLE 71: Europe Historic Review for Tissue Diagnostics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Billion for Years 2012 through 2019
    • TABLE 72: Europe 15-Year Perspective for Tissue Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2012, 2020 & 2027
    • TABLE 73: Europe Current & Future Analysis for Tissue Diagnostics by Product - Consumables and Instruments - Independent Analysis of Annual Sales in US$ Billion for the Years 2020 through 2027
    • TABLE 74: Europe Historic Review for Tissue Diagnostics by Product - Consumables and Instruments Markets - Independent Analysis of Annual Sales in US$ Billion for Years 2012 through 2019
    • TABLE 75: Europe 15-Year Perspective for Tissue Diagnostics by Product - Percentage Breakdown of Value Sales for Consumables and Instruments for the Years 2012, 2020 & 2027
    • TABLE 76: Europe Current & Future Analysis for Tissue Diagnostics by Technology - Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow - Independent Analysis of Annual Sales in US$ Billion for the Years 2020 through 2027
    • TABLE 77: Europe Historic Review for Tissue Diagnostics by Technology - Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow Markets - Independent Analysis of Annual Sales in US$ Billion for Years 2012 through 2019
    • TABLE 78: Europe 15-Year Perspective for Tissue Diagnostics by Technology - Percentage Breakdown of Value Sales for Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow for the Years 2012, 2020 & 2027
    • TABLE 79: Europe Current & Future Analysis for Tissue Diagnostics by End-Use - Hospitals, Pharma Companies, Research Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Billion for the Years 2020 through 2027
    • TABLE 80: Europe Historic Review for Tissue Diagnostics by End-Use - Hospitals, Pharma Companies, Research Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Billion for Years 2012 through 2019
    • TABLE 81: Europe 15-Year Perspective for Tissue Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Pharma Companies, Research Laboratories and Other End-Uses for the Years 2012, 2020 & 2027
  • FRANCE
    • TABLE 82: France Current & Future Analysis for Tissue Diagnostics by Product - Consumables and Instruments - Independent Analysis of Annual Sales in US$ Billion for the Years 2020 through 2027
    • TABLE 83: France Historic Review for Tissue Diagnostics by Product - Consumables and Instruments Markets - Independent Analysis of Annual Sales in US$ Billion for Years 2012 through 2019
    • TABLE 84: France 15-Year Perspective for Tissue Diagnostics by Product - Percentage Breakdown of Value Sales for Consumables and Instruments for the Years 2012, 2020 & 2027
    • TABLE 85: France Current & Future Analysis for Tissue Diagnostics by Technology - Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow - Independent Analysis of Annual Sales in US$ Billion for the Years 2020 through 2027
    • TABLE 86: France Historic Review for Tissue Diagnostics by Technology - Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow Markets - Independent Analysis of Annual Sales in US$ Billion for Years 2012 through 2019
    • TABLE 87: France 15-Year Perspective for Tissue Diagnostics by Technology - Percentage Breakdown of Value Sales for Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow for the Years 2012, 2020 & 2027
    • TABLE 88: France Current & Future Analysis for Tissue Diagnostics by End-Use - Hospitals, Pharma Companies, Research Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Billion for the Years 2020 through 2027
    • TABLE 89: France Historic Review for Tissue Diagnostics by End-Use - Hospitals, Pharma Companies, Research Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Billion for Years 2012 through 2019
    • TABLE 90: France 15-Year Perspective for Tissue Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Pharma Companies, Research Laboratories and Other End-Uses for the Years 2012, 2020 & 2027
  • GERMANY
    • TABLE 91: Germany Current & Future Analysis for Tissue Diagnostics by Product - Consumables and Instruments - Independent Analysis of Annual Sales in US$ Billion for the Years 2020 through 2027
    • TABLE 92: Germany Historic Review for Tissue Diagnostics by Product - Consumables and Instruments Markets - Independent Analysis of Annual Sales in US$ Billion for Years 2012 through 2019
    • TABLE 93: Germany 15-Year Perspective for Tissue Diagnostics by Product - Percentage Breakdown of Value Sales for Consumables and Instruments for the Years 2012, 2020 & 2027
    • TABLE 94: Germany Current & Future Analysis for Tissue Diagnostics by Technology - Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow - Independent Analysis of Annual Sales in US$ Billion for the Years 2020 through 2027
    • TABLE 95: Germany Historic Review for Tissue Diagnostics by Technology - Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow Markets - Independent Analysis of Annual Sales in US$ Billion for Years 2012 through 2019
    • TABLE 96: Germany 15-Year Perspective for Tissue Diagnostics by Technology - Percentage Breakdown of Value Sales for Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow for the Years 2012, 2020 & 2027
    • TABLE 97: Germany Current & Future Analysis for Tissue Diagnostics by End-Use - Hospitals, Pharma Companies, Research Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Billion for the Years 2020 through 2027
    • TABLE 98: Germany Historic Review for Tissue Diagnostics by End-Use - Hospitals, Pharma Companies, Research Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Billion for Years 2012 through 2019
    • TABLE 99: Germany 15-Year Perspective for Tissue Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Pharma Companies, Research Laboratories and Other End-Uses for the Years 2012, 2020 & 2027
  • ITALY
    • TABLE 100: Italy Current & Future Analysis for Tissue Diagnostics by Product - Consumables and Instruments - Independent Analysis of Annual Sales in US$ Billion for the Years 2020 through 2027
    • TABLE 101: Italy Historic Review for Tissue Diagnostics by Product - Consumables and Instruments Markets - Independent Analysis of Annual Sales in US$ Billion for Years 2012 through 2019
    • TABLE 102: Italy 15-Year Perspective for Tissue Diagnostics by Product - Percentage Breakdown of Value Sales for Consumables and Instruments for the Years 2012, 2020 & 2027
    • TABLE 103: Italy Current & Future Analysis for Tissue Diagnostics by Technology - Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow - Independent Analysis of Annual Sales in US$ Billion for the Years 2020 through 2027
    • TABLE 104: Italy Historic Review for Tissue Diagnostics by Technology - Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow Markets - Independent Analysis of Annual Sales in US$ Billion for Years 2012 through 2019
    • TABLE 105: Italy 15-Year Perspective for Tissue Diagnostics by Technology - Percentage Breakdown of Value Sales for Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow for the Years 2012, 2020 & 2027
    • TABLE 106: Italy Current & Future Analysis for Tissue Diagnostics by End-Use - Hospitals, Pharma Companies, Research Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Billion for the Years 2020 through 2027
    • TABLE 107: Italy Historic Review for Tissue Diagnostics by End-Use - Hospitals, Pharma Companies, Research Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Billion for Years 2012 through 2019
    • TABLE 108: Italy 15-Year Perspective for Tissue Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Pharma Companies, Research Laboratories and Other End-Uses for the Years 2012, 2020 & 2027
  • UNITED KINGDOM
    • TABLE 109: UK Current & Future Analysis for Tissue Diagnostics by Product - Consumables and Instruments - Independent Analysis of Annual Sales in US$ Billion for the Years 2020 through 2027
    • TABLE 110: UK Historic Review for Tissue Diagnostics by Product - Consumables and Instruments Markets - Independent Analysis of Annual Sales in US$ Billion for Years 2012 through 2019
    • TABLE 111: UK 15-Year Perspective for Tissue Diagnostics by Product - Percentage Breakdown of Value Sales for Consumables and Instruments for the Years 2012, 2020 & 2027
    • TABLE 112: UK Current & Future Analysis for Tissue Diagnostics by Technology - Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow - Independent Analysis of Annual Sales in US$ Billion for the Years 2020 through 2027
    • TABLE 113: UK Historic Review for Tissue Diagnostics by Technology - Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow Markets - Independent Analysis of Annual Sales in US$ Billion for Years 2012 through 2019
    • TABLE 114: UK 15-Year Perspective for Tissue Diagnostics by Technology - Percentage Breakdown of Value Sales for Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow for the Years 2012, 2020 & 2027
    • TABLE 115: UK Current & Future Analysis for Tissue Diagnostics by End-Use - Hospitals, Pharma Companies, Research Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Billion for the Years 2020 through 2027
    • TABLE 116: UK Historic Review for Tissue Diagnostics by End-Use - Hospitals, Pharma Companies, Research Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Billion for Years 2012 through 2019
    • TABLE 117: UK 15-Year Perspective for Tissue Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Pharma Companies, Research Laboratories and Other End-Uses for the Years 2012, 2020 & 2027
  • SPAIN
    • TABLE 118: Spain Current & Future Analysis for Tissue Diagnostics by Product - Consumables and Instruments - Independent Analysis of Annual Sales in US$ Billion for the Years 2020 through 2027
    • TABLE 119: Spain Historic Review for Tissue Diagnostics by Product - Consumables and Instruments Markets - Independent Analysis of Annual Sales in US$ Billion for Years 2012 through 2019
    • TABLE 120: Spain 15-Year Perspective for Tissue Diagnostics by Product - Percentage Breakdown of Value Sales for Consumables and Instruments for the Years 2012, 2020 & 2027
    • TABLE 121: Spain Current & Future Analysis for Tissue Diagnostics by Technology - Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow - Independent Analysis of Annual Sales in US$ Billion for the Years 2020 through 2027
    • TABLE 122: Spain Historic Review for Tissue Diagnostics by Technology - Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow Markets - Independent Analysis of Annual Sales in US$ Billion for Years 2012 through 2019
    • TABLE 123: Spain 15-Year Perspective for Tissue Diagnostics by Technology - Percentage Breakdown of Value Sales for Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow for the Years 2012, 2020 & 2027
    • TABLE 124: Spain Current & Future Analysis for Tissue Diagnostics by End-Use - Hospitals, Pharma Companies, Research Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Billion for the Years 2020 through 2027
    • TABLE 125: Spain Historic Review for Tissue Diagnostics by End-Use - Hospitals, Pharma Companies, Research Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Billion for Years 2012 through 2019
    • TABLE 126: Spain 15-Year Perspective for Tissue Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Pharma Companies, Research Laboratories and Other End-Uses for the Years 2012, 2020 & 2027
  • RUSSIA
    • TABLE 127: Russia Current & Future Analysis for Tissue Diagnostics by Product - Consumables and Instruments - Independent Analysis of Annual Sales in US$ Billion for the Years 2020 through 2027
    • TABLE 128: Russia Historic Review for Tissue Diagnostics by Product - Consumables and Instruments Markets - Independent Analysis of Annual Sales in US$ Billion for Years 2012 through 2019
    • TABLE 129: Russia 15-Year Perspective for Tissue Diagnostics by Product - Percentage Breakdown of Value Sales for Consumables and Instruments for the Years 2012, 2020 & 2027
    • TABLE 130: Russia Current & Future Analysis for Tissue Diagnostics by Technology - Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow - Independent Analysis of Annual Sales in US$ Billion for the Years 2020 through 2027
    • TABLE 131: Russia Historic Review for Tissue Diagnostics by Technology - Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow Markets - Independent Analysis of Annual Sales in US$ Billion for Years 2012 through 2019
    • TABLE 132: Russia 15-Year Perspective for Tissue Diagnostics by Technology - Percentage Breakdown of Value Sales for Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow for the Years 2012, 2020 & 2027
    • TABLE 133: Russia Current & Future Analysis for Tissue Diagnostics by End-Use - Hospitals, Pharma Companies, Research Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Billion for the Years 2020 through 2027
    • TABLE 134: Russia Historic Review for Tissue Diagnostics by End-Use - Hospitals, Pharma Companies, Research Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Billion for Years 2012 through 2019
    • TABLE 135: Russia 15-Year Perspective for Tissue Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Pharma Companies, Research Laboratories and Other End-Uses for the Years 2012, 2020 & 2027
  • REST OF EUROPE
    • TABLE 136: Rest of Europe Current & Future Analysis for Tissue Diagnostics by Product - Consumables and Instruments - Independent Analysis of Annual Sales in US$ Billion for the Years 2020 through 2027
    • TABLE 137: Rest of Europe Historic Review for Tissue Diagnostics by Product - Consumables and Instruments Markets - Independent Analysis of Annual Sales in US$ Billion for Years 2012 through 2019
    • TABLE 138: Rest of Europe 15-Year Perspective for Tissue Diagnostics by Product - Percentage Breakdown of Value Sales for Consumables and Instruments for the Years 2012, 2020 & 2027
    • TABLE 139: Rest of Europe Current & Future Analysis for Tissue Diagnostics by Technology - Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow - Independent Analysis of Annual Sales in US$ Billion for the Years 2020 through 2027
    • TABLE 140: Rest of Europe Historic Review for Tissue Diagnostics by Technology - Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow Markets - Independent Analysis of Annual Sales in US$ Billion for Years 2012 through 2019
    • TABLE 141: Rest of Europe 15-Year Perspective for Tissue Diagnostics by Technology - Percentage Breakdown of Value Sales for Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow for the Years 2012, 2020 & 2027
    • TABLE 142: Rest of Europe Current & Future Analysis for Tissue Diagnostics by End-Use - Hospitals, Pharma Companies, Research Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Billion for the Years 2020 through 2027
    • TABLE 143: Rest of Europe Historic Review for Tissue Diagnostics by End-Use - Hospitals, Pharma Companies, Research Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Billion for Years 2012 through 2019
    • TABLE 144: Rest of Europe 15-Year Perspective for Tissue Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Pharma Companies, Research Laboratories and Other End-Uses for the Years 2012, 2020 & 2027
  • ASIA-PACIFIC
    • TABLE 145: Asia-Pacific Current & Future Analysis for Tissue Diagnostics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Billion for Years 2020 through 2027
    • TABLE 146: Asia-Pacific Historic Review for Tissue Diagnostics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Billion for Years 2012 through 2019
    • TABLE 147: Asia-Pacific 15-Year Perspective for Tissue Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2012, 2020 & 2027
    • TABLE 148: Asia-Pacific Current & Future Analysis for Tissue Diagnostics by Product - Consumables and Instruments - Independent Analysis of Annual Sales in US$ Billion for the Years 2020 through 2027
    • TABLE 149: Asia-Pacific Historic Review for Tissue Diagnostics by Product - Consumables and Instruments Markets - Independent Analysis of Annual Sales in US$ Billion for Years 2012 through 2019
    • TABLE 150: Asia-Pacific 15-Year Perspective for Tissue Diagnostics by Product - Percentage Breakdown of Value Sales for Consumables and Instruments for the Years 2012, 2020 & 2027
    • TABLE 151: Asia-Pacific Current & Future Analysis for Tissue Diagnostics by Technology - Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow - Independent Analysis of Annual Sales in US$ Billion for the Years 2020 through 2027
    • TABLE 152: Asia-Pacific Historic Review for Tissue Diagnostics by Technology - Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow Markets - Independent Analysis of Annual Sales in US$ Billion for Years 2012 through 2019
    • TABLE 153: Asia-Pacific 15-Year Perspective for Tissue Diagnostics by Technology - Percentage Breakdown of Value Sales for Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow for the Years 2012, 2020 & 2027
    • TABLE 154: Asia-Pacific Current & Future Analysis for Tissue Diagnostics by End-Use - Hospitals, Pharma Companies, Research Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Billion for the Years 2020 through 2027
    • TABLE 155: Asia-Pacific Historic Review for Tissue Diagnostics by End-Use - Hospitals, Pharma Companies, Research Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Billion for Years 2012 through 2019
    • TABLE 156: Asia-Pacific 15-Year Perspective for Tissue Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Pharma Companies, Research Laboratories and Other End-Uses for the Years 2012, 2020 & 2027
  • AUSTRALIA
    • TABLE 157: Australia Current & Future Analysis for Tissue Diagnostics by Product - Consumables and Instruments - Independent Analysis of Annual Sales in US$ Billion for the Years 2020 through 2027
    • TABLE 158: Australia Historic Review for Tissue Diagnostics by Product - Consumables and Instruments Markets - Independent Analysis of Annual Sales in US$ Billion for Years 2012 through 2019
    • TABLE 159: Australia 15-Year Perspective for Tissue Diagnostics by Product - Percentage Breakdown of Value Sales for Consumables and Instruments for the Years 2012, 2020 & 2027
    • TABLE 160: Australia Current & Future Analysis for Tissue Diagnostics by Technology - Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow - Independent Analysis of Annual Sales in US$ Billion for the Years 2020 through 2027
    • TABLE 161: Australia Historic Review for Tissue Diagnostics by Technology - Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow Markets - Independent Analysis of Annual Sales in US$ Billion for Years 2012 through 2019
    • TABLE 162: Australia 15-Year Perspective for Tissue Diagnostics by Technology - Percentage Breakdown of Value Sales for Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow for the Years 2012, 2020 & 2027
    • TABLE 163: Australia Current & Future Analysis for Tissue Diagnostics by End-Use - Hospitals, Pharma Companies, Research Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Billion for the Years 2020 through 2027
    • TABLE 164: Australia Historic Review for Tissue Diagnostics by End-Use - Hospitals, Pharma Companies, Research Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Billion for Years 2012 through 2019
    • TABLE 165: Australia 15-Year Perspective for Tissue Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Pharma Companies, Research Laboratories and Other End-Uses for the Years 2012, 2020 & 2027
  • INDIA
    • TABLE 166: India Current & Future Analysis for Tissue Diagnostics by Product - Consumables and Instruments - Independent Analysis of Annual Sales in US$ Billion for the Years 2020 through 2027
    • TABLE 167: India Historic Review for Tissue Diagnostics by Product - Consumables and Instruments Markets - Independent Analysis of Annual Sales in US$ Billion for Years 2012 through 2019
    • TABLE 168: India 15-Year Perspective for Tissue Diagnostics by Product - Percentage Breakdown of Value Sales for Consumables and Instruments for the Years 2012, 2020 & 2027
    • TABLE 169: India Current & Future Analysis for Tissue Diagnostics by Technology - Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow - Independent Analysis of Annual Sales in US$ Billion for the Years 2020 through 2027
    • TABLE 170: India Historic Review for Tissue Diagnostics by Technology - Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow Markets - Independent Analysis of Annual Sales in US$ Billion for Years 2012 through 2019
    • TABLE 171: India 15-Year Perspective for Tissue Diagnostics by Technology - Percentage Breakdown of Value Sales for Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow for the Years 2012, 2020 & 2027
    • TABLE 172: India Current & Future Analysis for Tissue Diagnostics by End-Use - Hospitals, Pharma Companies, Research Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Billion for the Years 2020 through 2027
    • TABLE 173: India Historic Review for Tissue Diagnostics by End-Use - Hospitals, Pharma Companies, Research Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Billion for Years 2012 through 2019
    • TABLE 174: India 15-Year Perspective for Tissue Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Pharma Companies, Research Laboratories and Other End-Uses for the Years 2012, 2020 & 2027
  • SOUTH KOREA
    • TABLE 175: South Korea Current & Future Analysis for Tissue Diagnostics by Product - Consumables and Instruments - Independent Analysis of Annual Sales in US$ Billion for the Years 2020 through 2027
    • TABLE 176: South Korea Historic Review for Tissue Diagnostics by Product - Consumables and Instruments Markets - Independent Analysis of Annual Sales in US$ Billion for Years 2012 through 2019
    • TABLE 177: South Korea 15-Year Perspective for Tissue Diagnostics by Product - Percentage Breakdown of Value Sales for Consumables and Instruments for the Years 2012, 2020 & 2027
    • TABLE 178: South Korea Current & Future Analysis for Tissue Diagnostics by Technology - Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow - Independent Analysis of Annual Sales in US$ Billion for the Years 2020 through 2027
    • TABLE 179: South Korea Historic Review for Tissue Diagnostics by Technology - Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow Markets - Independent Analysis of Annual Sales in US$ Billion for Years 2012 through 2019
    • TABLE 180: South Korea 15-Year Perspective for Tissue Diagnostics by Technology - Percentage Breakdown of Value Sales for Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow for the Years 2012, 2020 & 2027
    • TABLE 181: South Korea Current & Future Analysis for Tissue Diagnostics by End-Use - Hospitals, Pharma Companies, Research Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Billion for the Years 2020 through 2027
    • TABLE 182: South Korea Historic Review for Tissue Diagnostics by End-Use - Hospitals, Pharma Companies, Research Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Billion for Years 2012 through 2019
    • TABLE 183: South Korea 15-Year Perspective for Tissue Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Pharma Companies, Research Laboratories and Other End-Uses for the Years 2012, 2020 & 2027
  • REST OF ASIA-PACIFIC
    • TABLE 184: Rest of Asia-Pacific Current & Future Analysis for Tissue Diagnostics by Product - Consumables and Instruments - Independent Analysis of Annual Sales in US$ Billion for the Years 2020 through 2027
    • TABLE 185: Rest of Asia-Pacific Historic Review for Tissue Diagnostics by Product - Consumables and Instruments Markets - Independent Analysis of Annual Sales in US$ Billion for Years 2012 through 2019
    • TABLE 186: Rest of Asia-Pacific 15-Year Perspective for Tissue Diagnostics by Product - Percentage Breakdown of Value Sales for Consumables and Instruments for the Years 2012, 2020 & 2027
    • TABLE 187: Rest of Asia-Pacific Current & Future Analysis for Tissue Diagnostics by Technology - Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow - Independent Analysis of Annual Sales in US$ Billion for the Years 2020 through 2027
    • TABLE 188: Rest of Asia-Pacific Historic Review for Tissue Diagnostics by Technology - Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow Markets - Independent Analysis of Annual Sales in US$ Billion for Years 2012 through 2019
    • TABLE 189: Rest of Asia-Pacific 15-Year Perspective for Tissue Diagnostics by Technology - Percentage Breakdown of Value Sales for Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow for the Years 2012, 2020 & 2027
    • TABLE 190: Rest of Asia-Pacific Current & Future Analysis for Tissue Diagnostics by End-Use - Hospitals, Pharma Companies, Research Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Billion for the Years 2020 through 2027
    • TABLE 191: Rest of Asia-Pacific Historic Review for Tissue Diagnostics by End-Use - Hospitals, Pharma Companies, Research Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Billion for Years 2012 through 2019
    • TABLE 192: Rest of Asia-Pacific 15-Year Perspective for Tissue Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Pharma Companies, Research Laboratories and Other End-Uses for the Years 2012, 2020 & 2027
  • LATIN AMERICA
    • TABLE 193: Latin America Current & Future Analysis for Tissue Diagnostics by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Billion for Years 2020 through 2027
    • TABLE 194: Latin America Historic Review for Tissue Diagnostics by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Billion for Years 2012 through 2019
    • TABLE 195: Latin America 15-Year Perspective for Tissue Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2012, 2020 & 2027
    • TABLE 196: Latin America Current & Future Analysis for Tissue Diagnostics by Product - Consumables and Instruments - Independent Analysis of Annual Sales in US$ Billion for the Years 2020 through 2027
    • TABLE 197: Latin America Historic Review for Tissue Diagnostics by Product - Consumables and Instruments Markets - Independent Analysis of Annual Sales in US$ Billion for Years 2012 through 2019
    • TABLE 198: Latin America 15-Year Perspective for Tissue Diagnostics by Product - Percentage Breakdown of Value Sales for Consumables and Instruments for the Years 2012, 2020 & 2027
    • TABLE 199: Latin America Current & Future Analysis for Tissue Diagnostics by Technology - Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow - Independent Analysis of Annual Sales in US$ Billion for the Years 2020 through 2027
    • TABLE 200: Latin America Historic Review for Tissue Diagnostics by Technology - Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow Markets - Independent Analysis of Annual Sales in US$ Billion for Years 2012 through 2019
    • TABLE 201: Latin America 15-Year Perspective for Tissue Diagnostics by Technology - Percentage Breakdown of Value Sales for Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow for the Years 2012, 2020 & 2027
    • TABLE 202: Latin America Current & Future Analysis for Tissue Diagnostics by End-Use - Hospitals, Pharma Companies, Research Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Billion for the Years 2020 through 2027
    • TABLE 203: Latin America Historic Review for Tissue Diagnostics by End-Use - Hospitals, Pharma Companies, Research Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Billion for Years 2012 through 2019
    • TABLE 204: Latin America 15-Year Perspective for Tissue Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Pharma Companies, Research Laboratories and Other End-Uses for the Years 2012, 2020 & 2027
  • ARGENTINA
    • TABLE 205: Argentina Current & Future Analysis for Tissue Diagnostics by Product - Consumables and Instruments - Independent Analysis of Annual Sales in US$ Billion for the Years 2020 through 2027
    • TABLE 206: Argentina Historic Review for Tissue Diagnostics by Product - Consumables and Instruments Markets - Independent Analysis of Annual Sales in US$ Billion for Years 2012 through 2019
    • TABLE 207: Argentina 15-Year Perspective for Tissue Diagnostics by Product - Percentage Breakdown of Value Sales for Consumables and Instruments for the Years 2012, 2020 & 2027
    • TABLE 208: Argentina Current & Future Analysis for Tissue Diagnostics by Technology - Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow - Independent Analysis of Annual Sales in US$ Billion for the Years 2020 through 2027
    • TABLE 209: Argentina Historic Review for Tissue Diagnostics by Technology - Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow Markets - Independent Analysis of Annual Sales in US$ Billion for Years 2012 through 2019
    • TABLE 210: Argentina 15-Year Perspective for Tissue Diagnostics by Technology - Percentage Breakdown of Value Sales for Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow for the Years 2012, 2020 & 2027
    • TABLE 211: Argentina Current & Future Analysis for Tissue Diagnostics by End-Use - Hospitals, Pharma Companies, Research Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Billion for the Years 2020 through 2027
    • TABLE 212: Argentina Historic Review for Tissue Diagnostics by End-Use - Hospitals, Pharma Companies, Research Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Billion for Years 2012 through 2019
    • TABLE 213: Argentina 15-Year Perspective for Tissue Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Pharma Companies, Research Laboratories and Other End-Uses for the Years 2012, 2020 & 2027
  • BRAZIL
    • TABLE 214: Brazil Current & Future Analysis for Tissue Diagnostics by Product - Consumables and Instruments - Independent Analysis of Annual Sales in US$ Billion for the Years 2020 through 2027
    • TABLE 215: Brazil Historic Review for Tissue Diagnostics by Product - Consumables and Instruments Markets - Independent Analysis of Annual Sales in US$ Billion for Years 2012 through 2019
    • TABLE 216: Brazil 15-Year Perspective for Tissue Diagnostics by Product - Percentage Breakdown of Value Sales for Consumables and Instruments for the Years 2012, 2020 & 2027
    • TABLE 217: Brazil Current & Future Analysis for Tissue Diagnostics by Technology - Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow - Independent Analysis of Annual Sales in US$ Billion for the Years 2020 through 2027
    • TABLE 218: Brazil Historic Review for Tissue Diagnostics by Technology - Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow Markets - Independent Analysis of Annual Sales in US$ Billion for Years 2012 through 2019
    • TABLE 219: Brazil 15-Year Perspective for Tissue Diagnostics by Technology - Percentage Breakdown of Value Sales for Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow for the Years 2012, 2020 & 2027
    • TABLE 220: Brazil Current & Future Analysis for Tissue Diagnostics by End-Use - Hospitals, Pharma Companies, Research Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Billion for the Years 2020 through 2027
    • TABLE 221: Brazil Historic Review for Tissue Diagnostics by End-Use - Hospitals, Pharma Companies, Research Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Billion for Years 2012 through 2019
    • TABLE 222: Brazil 15-Year Perspective for Tissue Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Pharma Companies, Research Laboratories and Other End-Uses for the Years 2012, 2020 & 2027
  • MEXICO
    • TABLE 223: Mexico Current & Future Analysis for Tissue Diagnostics by Product - Consumables and Instruments - Independent Analysis of Annual Sales in US$ Billion for the Years 2020 through 2027
    • TABLE 224: Mexico Historic Review for Tissue Diagnostics by Product - Consumables and Instruments Markets - Independent Analysis of Annual Sales in US$ Billion for Years 2012 through 2019
    • TABLE 225: Mexico 15-Year Perspective for Tissue Diagnostics by Product - Percentage Breakdown of Value Sales for Consumables and Instruments for the Years 2012, 2020 & 2027
    • TABLE 226: Mexico Current & Future Analysis for Tissue Diagnostics by Technology - Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow - Independent Analysis of Annual Sales in US$ Billion for the Years 2020 through 2027
    • TABLE 227: Mexico Historic Review for Tissue Diagnostics by Technology - Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow Markets - Independent Analysis of Annual Sales in US$ Billion for Years 2012 through 2019
    • TABLE 228: Mexico 15-Year Perspective for Tissue Diagnostics by Technology - Percentage Breakdown of Value Sales for Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow for the Years 2012, 2020 & 2027
    • TABLE 229: Mexico Current & Future Analysis for Tissue Diagnostics by End-Use - Hospitals, Pharma Companies, Research Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Billion for the Years 2020 through 2027
    • TABLE 230: Mexico Historic Review for Tissue Diagnostics by End-Use - Hospitals, Pharma Companies, Research Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Billion for Years 2012 through 2019
    • TABLE 231: Mexico 15-Year Perspective for Tissue Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Pharma Companies, Research Laboratories and Other End-Uses for the Years 2012, 2020 & 2027
  • REST OF LATIN AMERICA
    • TABLE 232: Rest of Latin America Current & Future Analysis for Tissue Diagnostics by Product - Consumables and Instruments - Independent Analysis of Annual Sales in US$ Billion for the Years 2020 through 2027
    • TABLE 233: Rest of Latin America Historic Review for Tissue Diagnostics by Product - Consumables and Instruments Markets - Independent Analysis of Annual Sales in US$ Billion for Years 2012 through 2019
    • TABLE 234: Rest of Latin America 15-Year Perspective for Tissue Diagnostics by Product - Percentage Breakdown of Value Sales for Consumables and Instruments for the Years 2012, 2020 & 2027
    • TABLE 235: Rest of Latin America Current & Future Analysis for Tissue Diagnostics by Technology - Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow - Independent Analysis of Annual Sales in US$ Billion for the Years 2020 through 2027
    • TABLE 236: Rest of Latin America Historic Review for Tissue Diagnostics by Technology - Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow Markets - Independent Analysis of Annual Sales in US$ Billion for Years 2012 through 2019
    • TABLE 237: Rest of Latin America 15-Year Perspective for Tissue Diagnostics by Technology - Percentage Breakdown of Value Sales for Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow for the Years 2012, 2020 & 2027
    • TABLE 238: Rest of Latin America Current & Future Analysis for Tissue Diagnostics by End-Use - Hospitals, Pharma Companies, Research Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Billion for the Years 2020 through 2027
    • TABLE 239: Rest of Latin America Historic Review for Tissue Diagnostics by End-Use - Hospitals, Pharma Companies, Research Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Billion for Years 2012 through 2019
    • TABLE 240: Rest of Latin America 15-Year Perspective for Tissue Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Pharma Companies, Research Laboratories and Other End-Uses for the Years 2012, 2020 & 2027
  • MIDDLE EAST
    • TABLE 241: Middle East Current & Future Analysis for Tissue Diagnostics by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Billion for Years 2020 through 2027
    • TABLE 242: Middle East Historic Review for Tissue Diagnostics by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Billion for Years 2012 through 2019
    • TABLE 243: Middle East 15-Year Perspective for Tissue Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2012, 2020 & 2027
    • TABLE 244: Middle East Current & Future Analysis for Tissue Diagnostics by Product - Consumables and Instruments - Independent Analysis of Annual Sales in US$ Billion for the Years 2020 through 2027
    • TABLE 245: Middle East Historic Review for Tissue Diagnostics by Product - Consumables and Instruments Markets - Independent Analysis of Annual Sales in US$ Billion for Years 2012 through 2019
    • TABLE 246: Middle East 15-Year Perspective for Tissue Diagnostics by Product - Percentage Breakdown of Value Sales for Consumables and Instruments for the Years 2012, 2020 & 2027
    • TABLE 247: Middle East Current & Future Analysis for Tissue Diagnostics by Technology - Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow - Independent Analysis of Annual Sales in US$ Billion for the Years 2020 through 2027
    • TABLE 248: Middle East Historic Review for Tissue Diagnostics by Technology - Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow Markets - Independent Analysis of Annual Sales in US$ Billion for Years 2012 through 2019
    • TABLE 249: Middle East 15-Year Perspective for Tissue Diagnostics by Technology - Percentage Breakdown of Value Sales for Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow for the Years 2012, 2020 & 2027
    • TABLE 250: Middle East Current & Future Analysis for Tissue Diagnostics by End-Use - Hospitals, Pharma Companies, Research Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Billion for the Years 2020 through 2027
    • TABLE 251: Middle East Historic Review for Tissue Diagnostics by End-Use - Hospitals, Pharma Companies, Research Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Billion for Years 2012 through 2019
    • TABLE 252: Middle East 15-Year Perspective for Tissue Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Pharma Companies, Research Laboratories and Other End-Uses for the Years 2012, 2020 & 2027
  • IRAN
    • TABLE 253: Iran Current & Future Analysis for Tissue Diagnostics by Product - Consumables and Instruments - Independent Analysis of Annual Sales in US$ Billion for the Years 2020 through 2027
    • TABLE 254: Iran Historic Review for Tissue Diagnostics by Product - Consumables and Instruments Markets - Independent Analysis of Annual Sales in US$ Billion for Years 2012 through 2019
    • TABLE 255: Iran 15-Year Perspective for Tissue Diagnostics by Product - Percentage Breakdown of Value Sales for Consumables and Instruments for the Years 2012, 2020 & 2027
    • TABLE 256: Iran Current & Future Analysis for Tissue Diagnostics by Technology - Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow - Independent Analysis of Annual Sales in US$ Billion for the Years 2020 through 2027
    • TABLE 257: Iran Historic Review for Tissue Diagnostics by Technology - Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow Markets - Independent Analysis of Annual Sales in US$ Billion for Years 2012 through 2019
    • TABLE 258: Iran 15-Year Perspective for Tissue Diagnostics by Technology - Percentage Breakdown of Value Sales for Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow for the Years 2012, 2020 & 2027
    • TABLE 259: Iran Current & Future Analysis for Tissue Diagnostics by End-Use - Hospitals, Pharma Companies, Research Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Billion for the Years 2020 through 2027
    • TABLE 260: Iran Historic Review for Tissue Diagnostics by End-Use - Hospitals, Pharma Companies, Research Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Billion for Years 2012 through 2019
    • TABLE 261: Iran 15-Year Perspective for Tissue Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Pharma Companies, Research Laboratories and Other End-Uses for the Years 2012, 2020 & 2027
  • ISRAEL
    • TABLE 262: Israel Current & Future Analysis for Tissue Diagnostics by Product - Consumables and Instruments - Independent Analysis of Annual Sales in US$ Billion for the Years 2020 through 2027
    • TABLE 263: Israel Historic Review for Tissue Diagnostics by Product - Consumables and Instruments Markets - Independent Analysis of Annual Sales in US$ Billion for Years 2012 through 2019
    • TABLE 264: Israel 15-Year Perspective for Tissue Diagnostics by Product - Percentage Breakdown of Value Sales for Consumables and Instruments for the Years 2012, 2020 & 2027
    • TABLE 265: Israel Current & Future Analysis for Tissue Diagnostics by Technology - Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow - Independent Analysis of Annual Sales in US$ Billion for the Years 2020 through 2027
    • TABLE 266: Israel Historic Review for Tissue Diagnostics by Technology - Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow Markets - Independent Analysis of Annual Sales in US$ Billion for Years 2012 through 2019
    • TABLE 267: Israel 15-Year Perspective for Tissue Diagnostics by Technology - Percentage Breakdown of Value Sales for Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow for the Years 2012, 2020 & 2027
    • TABLE 268: Israel Current & Future Analysis for Tissue Diagnostics by End-Use - Hospitals, Pharma Companies, Research Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Billion for the Years 2020 through 2027
    • TABLE 269: Israel Historic Review for Tissue Diagnostics by End-Use - Hospitals, Pharma Companies, Research Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Billion for Years 2012 through 2019
    • TABLE 270: Israel 15-Year Perspective for Tissue Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Pharma Companies, Research Laboratories and Other End-Uses for the Years 2012, 2020 & 2027
  • SAUDI ARABIA
    • TABLE 271: Saudi Arabia Current & Future Analysis for Tissue Diagnostics by Product - Consumables and Instruments - Independent Analysis of Annual Sales in US$ Billion for the Years 2020 through 2027
    • TABLE 272: Saudi Arabia Historic Review for Tissue Diagnostics by Product - Consumables and Instruments Markets - Independent Analysis of Annual Sales in US$ Billion for Years 2012 through 2019
    • TABLE 273: Saudi Arabia 15-Year Perspective for Tissue Diagnostics by Product - Percentage Breakdown of Value Sales for Consumables and Instruments for the Years 2012, 2020 & 2027
    • TABLE 274: Saudi Arabia Current & Future Analysis for Tissue Diagnostics by Technology - Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow - Independent Analysis of Annual Sales in US$ Billion for the Years 2020 through 2027
    • TABLE 275: Saudi Arabia Historic Review for Tissue Diagnostics by Technology - Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow Markets - Independent Analysis of Annual Sales in US$ Billion for Years 2012 through 2019
    • TABLE 276: Saudi Arabia 15-Year Perspective for Tissue Diagnostics by Technology - Percentage Breakdown of Value Sales for Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow for the Years 2012, 2020 & 2027
    • TABLE 277: Saudi Arabia Current & Future Analysis for Tissue Diagnostics by End-Use - Hospitals, Pharma Companies, Research Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Billion for the Years 2020 through 2027
    • TABLE 278: Saudi Arabia Historic Review for Tissue Diagnostics by End-Use - Hospitals, Pharma Companies, Research Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Billion for Years 2012 through 2019
    • TABLE 279: Saudi Arabia 15-Year Perspective for Tissue Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Pharma Companies, Research Laboratories and Other End-Uses for the Years 2012, 2020 & 2027
  • UNITED ARAB EMIRATES
    • TABLE 280: UAE Current & Future Analysis for Tissue Diagnostics by Product - Consumables and Instruments - Independent Analysis of Annual Sales in US$ Billion for the Years 2020 through 2027
    • TABLE 281: UAE Historic Review for Tissue Diagnostics by Product - Consumables and Instruments Markets - Independent Analysis of Annual Sales in US$ Billion for Years 2012 through 2019
    • TABLE 282: UAE 15-Year Perspective for Tissue Diagnostics by Product - Percentage Breakdown of Value Sales for Consumables and Instruments for the Years 2012, 2020 & 2027
    • TABLE 283: UAE Current & Future Analysis for Tissue Diagnostics by Technology - Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow - Independent Analysis of Annual Sales in US$ Billion for the Years 2020 through 2027
    • TABLE 284: UAE Historic Review for Tissue Diagnostics by Technology - Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow Markets - Independent Analysis of Annual Sales in US$ Billion for Years 2012 through 2019
    • TABLE 285: UAE 15-Year Perspective for Tissue Diagnostics by Technology - Percentage Breakdown of Value Sales for Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow for the Years 2012, 2020 & 2027
    • TABLE 286: UAE Current & Future Analysis for Tissue Diagnostics by End-Use - Hospitals, Pharma Companies, Research Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Billion for the Years 2020 through 2027
    • TABLE 287: UAE Historic Review for Tissue Diagnostics by End-Use - Hospitals, Pharma Companies, Research Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Billion for Years 2012 through 2019
    • TABLE 288: UAE 15-Year Perspective for Tissue Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Pharma Companies, Research Laboratories and Other End-Uses for the Years 2012, 2020 & 2027
  • REST OF MIDDLE EAST
    • TABLE 289: Rest of Middle East Current & Future Analysis for Tissue Diagnostics by Product - Consumables and Instruments - Independent Analysis of Annual Sales in US$ Billion for the Years 2020 through 2027
    • TABLE 290: Rest of Middle East Historic Review for Tissue Diagnostics by Product - Consumables and Instruments Markets - Independent Analysis of Annual Sales in US$ Billion for Years 2012 through 2019
    • TABLE 291: Rest of Middle East 15-Year Perspective for Tissue Diagnostics by Product - Percentage Breakdown of Value Sales for Consumables and Instruments for the Years 2012, 2020 & 2027
    • TABLE 292: Rest of Middle East Current & Future Analysis for Tissue Diagnostics by Technology - Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow - Independent Analysis of Annual Sales in US$ Billion for the Years 2020 through 2027
    • TABLE 293: Rest of Middle East Historic Review for Tissue Diagnostics by Technology - Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow Markets - Independent Analysis of Annual Sales in US$ Billion for Years 2012 through 2019
    • TABLE 294: Rest of Middle East 15-Year Perspective for Tissue Diagnostics by Technology - Percentage Breakdown of Value Sales for Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow for the Years 2012, 2020 & 2027
    • TABLE 295: Rest of Middle East Current & Future Analysis for Tissue Diagnostics by End-Use - Hospitals, Pharma Companies, Research Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Billion for the Years 2020 through 2027
    • TABLE 296: Rest of Middle East Historic Review for Tissue Diagnostics by End-Use - Hospitals, Pharma Companies, Research Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Billion for Years 2012 through 2019
    • TABLE 297: Rest of Middle East 15-Year Perspective for Tissue Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Pharma Companies, Research Laboratories and Other End-Uses for the Years 2012, 2020 & 2027
  • AFRICA
    • TABLE 298: Africa Current & Future Analysis for Tissue Diagnostics by Product - Consumables and Instruments - Independent Analysis of Annual Sales in US$ Billion for the Years 2020 through 2027
    • TABLE 299: Africa Historic Review for Tissue Diagnostics by Product - Consumables and Instruments Markets - Independent Analysis of Annual Sales in US$ Billion for Years 2012 through 2019
    • TABLE 300: Africa 15-Year Perspective for Tissue Diagnostics by Product - Percentage Breakdown of Value Sales for Consumables and Instruments for the Years 2012, 2020 & 2027
    • TABLE 301: Africa Current & Future Analysis for Tissue Diagnostics by Technology - Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow - Independent Analysis of Annual Sales in US$ Billion for the Years 2020 through 2027
    • TABLE 302: Africa Historic Review for Tissue Diagnostics by Technology - Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow Markets - Independent Analysis of Annual Sales in US$ Billion for Years 2012 through 2019
    • TABLE 303: Africa 15-Year Perspective for Tissue Diagnostics by Technology - Percentage Breakdown of Value Sales for Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow for the Years 2012, 2020 & 2027
    • TABLE 304: Africa Current & Future Analysis for Tissue Diagnostics by End-Use - Hospitals, Pharma Companies, Research Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Billion for the Years 2020 through 2027
    • TABLE 305: Africa Historic Review for Tissue Diagnostics by End-Use - Hospitals, Pharma Companies, Research Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Billion for Years 2012 through 2019
    • TABLE 306: Africa 15-Year Perspective for Tissue Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Pharma Companies, Research Laboratories and Other End-Uses for the Years 2012, 2020 & 2027

IV. COMPETITION

  • Total Companies Profiled: 37
株式会社グローバルインフォメーション
© Copyright 1996-2021, Global Information, Inc. All rights reserved.